Rx0000083 |
Laboratoire HRA Pharma |
03/31/2019 |
76336008060 |
Antineoplastic |
03/01/2019 |
359.05 |
839.00 |
None |
Single Source Drug |
None |
1 |
None |
1 |
None |
1 |
03/16/2018 |
Bristol Myers Squibb |
None |
1 |
No comment |
479.95 |
None |
1970 |
None |
None |
Column 6: Patent(s) expired. Product FDA approved 1970.
Column 21: WAC at Intro to Market unknown. Introducted to U.S. market in 1970. |
Rx0000083 |
Laboratoire HRA Pharma |
09/30/2019 |
76336008060 |
Lysodren (mitotane) 100 mg tablets |
07/01/2019 |
359.05 |
839.00 |
None |
Single Source Drug |
None |
1 |
None |
1 |
None |
1 |
03/14/2018 |
Bristol Myers Squibb |
None |
1 |
None |
479.95 |
479.95 |
1970 |
157.44 |
None |
The exact year of BMS's Lysodren introduction is not known.
Lysodren was FDA approved in 1970. |
Rx0000083 |
Laboratoire HRA Pharma |
06/30/2019 |
76336045518 |
Metopirone (metryapone) 250 mg capsules |
04/09/2019 |
34.59 |
383.95 |
01/01/1981 |
Single Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
HRA Pharma acquired Metopirone from Novartis in 2011 (exact date unknown). |
Rx0000083 |
Laboratoire HRA Pharma |
09/30/2019 |
76336045518 |
Metopirone (metryapone) 250 mg capsules |
07/01/2019 |
34.56 |
383.95 |
01/01/1981 |
Single Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
HRA Pharma acquired Metopirone from Novartis in 2011 (exact date unknown). |
Rx0000089 |
Lannett Company, Inc. |
03/31/2019 |
54838052340 |
Fluoxetine Oral Solution 20mg/5ml |
01/11/2019 |
60.00 |
69.00 |
None |
Non-innovator Multiple Source Drug |
None |
1 |
New serialization/software costs, production line enhancements were factors in the price increase. Continued supply of market demand not sustainable without a price adjustment. |
None |
n/a |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
No other price increases over that last five years other than the last one in 1/11/2019 |
Rx0000089 |
Lannett Company, Inc. |
03/31/2019 |
54838050115 |
Haloperidol Oral Solution 2mg/ml |
01/11/2019 |
14.87 |
20.86 |
None |
Non-innovator Multiple Source Drug |
None |
1 |
Product API cost increases, new serialization/software costs, production line enhancements were factors in the price increase. Continued supply of market demand not sustainable without a price adjustment. |
None |
n/a |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
No other price increases over that last five years other than the last one in 1/11/2019 |
Rx0000089 |
Lannett Company, Inc. |
03/31/2019 |
54838050140 |
Haloperidol Oral Solution 2mg/ml |
01/11/2019 |
19.33 |
28.32 |
None |
Non-innovator Multiple Source Drug |
None |
1 |
Product API cost increases, new serialization/software costs, production line enhancements were factors in the price increase. Continued supply of market demand not sustainable without a price adjustment. |
None |
n/a |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
No other price increases over that last five years other than the last one in 1/11/2019 |
Rx0000089 |
Lannett Company, Inc. |
03/31/2019 |
54838055080 |
Ranitidine Syrup 15mg/ml |
01/11/2019 |
57.00 |
75.00 |
None |
Non-innovator Multiple Source Drug |
None |
1 |
New serialization/software costs, production line enhancements were factors in the price increase. Continued supply of market demand not sustainable without a price adjustment. |
None |
n/a |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
No other price increases over that last five years other than the last one in 1/11/2019 |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994001104 |
Definity® Vial for (Perflutren Lipid Microsphere) Injectable Solution |
01/01/2019 |
91.99 |
1011.92 |
03/16/2037 |
Single Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994001116 |
Definity® Vial for (Perflutren Lipid Microsphere) Injectable Solution |
01/01/2019 |
367.97 |
4047.67 |
03/16/2037 |
Single Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994012106 |
Gallium-67 (Gallium Citrate Ga67 Injection) |
01/01/2019 |
72.10 |
793.13 |
None |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994012108 |
Gallium-67 (Gallium Citrate Ga67 Injection) |
01/01/2019 |
96.13 |
1057.48 |
None |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994012113 |
Gallium-67 (Gallium Citrate Ga67 Injection) |
01/01/2019 |
144.19 |
1586.12 |
None |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994012119 |
Gallium-67 (Gallium Citrate Ga67 Injection) |
01/01/2019 |
216.30 |
2379.25 |
None |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009101 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
320.61 |
6735.05 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009103 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
374.70 |
7868.63 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009104 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
404.60 |
8496.69 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009105 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
435.65 |
9148.64 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009106 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
492.06 |
10333.31 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009107 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
576.47 |
12105.91 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009109 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
701.50 |
14731.49 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009110 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
824.78 |
17320.35 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009111 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
1014.48 |
21304.05 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009112 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
1247.81 |
26203.96 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009136 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
206.40 |
4334.38 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009173 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
260.42 |
5468.91 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009192 |
LEU TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
286.29 |
6012.16 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994000602 |
NEUROLITE® (Kit for the Preparation of Technetium Tc99m Bicisate for Injection) |
01/01/2019 |
538.14 |
5919.57 |
None |
Single Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994001601 |
QUADRAMET® (Samarium Sm 153 Lexidronam Injection) |
01/01/2019 |
1383.42 |
15217.64 |
None |
Single Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009001 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
259.41 |
5447.56 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009003 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
303.06 |
6364.35 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009004 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
327.25 |
6872.33 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009005 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
352.36 |
7399.66 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009006 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
397.99 |
8357.82 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009007 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
466.27 |
9791.55 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009009 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
567.39 |
11915.18 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009010 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
667.10 |
14009.11 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009011 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
820.53 |
17231.22 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009012 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
1009.26 |
21194.36 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009036 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
166.94 |
3505.77 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009073 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
210.64 |
4423.37 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994009092 |
TechneLite® (Technetium Tc99m Generator) |
01/01/2019 |
231.56 |
4862.76 |
07/01/2029 |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994012711 |
Xenon-133 (Xenon Xe 133 Gas) |
01/01/2019 |
25.63 |
281.89 |
None |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994012715 |
Xenon-133 (Xenon Xe 133 Gas) |
01/01/2019 |
95.32 |
1048.56 |
None |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994012821 |
Xenon-133 (Xenon Xe 133 Gas) |
01/01/2019 |
41.55 |
457.09 |
None |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000009 |
Lantheus Medical Imaging, Inc. |
03/31/2019 |
11994012825 |
Xenon-133 (Xenon Xe 133 Gas) |
01/01/2019 |
194.13 |
2135.40 |
None |
Innovator Multiple Source Drug |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000196 |
Lexicon Pharmaceuticals |
09/30/2019 |
70183012584 |
XERMELO Telotristat Ethyl 250 mg 84 tablets |
07/02/2019 |
1089.00 |
6253.00 |
12/11/2027 |
Single Source Drug |
None |
1 |
None |
1 |
no change |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Product developed internally. No acquisition. |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386082019 |
Northera 100mg. 90 Capsules |
01/07/2019 |
233.70 |
2594.26 |
02/18/2021 |
Single Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
06/23/2014 |
"Chelsea Therapeutics International, Ltd." |
None |
1 |
"The Acquisition Price was left blank since Lundbeck acquired the rights to Northera through the purchase of Chelsea Therapeutics International, Ltd. for USD 6.44 per share in cash and non-transferable contingent value rights that may pay up to an additional USD 1.5 per share upon achievement of certain sales milestones, in each case without interest and subject to any required withholding of taxes." |
1409.00 |
None |
2014 |
1409.00 |
None |
WAC at acquisition is the same as WAC at introduction given that Northera did not launch until after acquisition. |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386082119 |
Northera 200mg. 90 Capsules |
01/07/2019 |
467.39 |
5188.51 |
02/18/2021 |
Single Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
06/23/2014 |
"Chelsea Therapeutics International, Ltd." |
None |
1 |
"The Acquisition Price was left blank since Lundbeck acquired the rights to Northera through the purchase of Chelsea Therapeutics International, Ltd. for USD 6.44 per share in cash and non-transferable contingent value rights that may pay up to an additional USD 1.5 per share upon achievement of certain sales milestones, in each case without interest and subject to any required withholding of taxes." |
2818.00 |
None |
2014 |
2818.00 |
None |
WAC at acquisition is the same as WAC at introduction given that Northera did not launch until after acquisition. |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386082219 |
Northera 300mg. 90 Capsules |
01/07/2019 |
701.09 |
7782.78 |
02/18/2021 |
Single Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
06/23/2014 |
"Chelsea Therapeutics International, Ltd." |
None |
1 |
"The Acquisition Price was left blank since Lundbeck acquired the rights to Northera through the purchase of Chelsea Therapeutics International, Ltd. for USD 6.44 per share in cash and non-transferable contingent value rights that may pay up to an additional USD 1.5 per share upon achievement of certain sales milestones, in each case without interest and subject to any required withholding of taxes." |
4227.00 |
None |
2014 |
4227.00 |
None |
WAC at acquisition is the same as WAC at introduction given that Northera did not launch until after acquisition. |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386031401 |
Onfi 10mg. 100 Tablets |
01/07/2019 |
181.22 |
2011.74 |
None |
Innovator Multiple Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386031501 |
Onfi 20mg. 100 Tablets |
01/07/2019 |
362.44 |
4023.44 |
None |
Innovator Multiple Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386031321 |
Onfi Oral Suspension 2.5mg/mL 120mL Bottle |
01/07/2019 |
95.22 |
1056.99 |
None |
Innovator Multiple Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386011101 |
Sabril 500mg. 100 Tablets |
01/07/2019 |
1316.25 |
14611.73 |
None |
Innovator Multiple Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386021165 |
Sabril 500mg. 50 Packets 500mg. each |
01/07/2019 |
658.13 |
7305.87 |
None |
Innovator Multiple Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386042101 |
Xenazine 12.5mg. 112 Tablets |
01/07/2019 |
1270.09 |
14099.29 |
None |
Innovator Multiple Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000025 |
Lundbeck LLC |
03/31/2019 |
67386042201 |
Xenazine 25.0mg. 112 Tablets |
01/07/2019 |
2540.18 |
28198.58 |
None |
Innovator Multiple Source Drug |
None |
1 |
"Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." |
None |
This WAC increase is not necessitated by a change or improvement in the prescription drug. |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |